S&P 500 Consumer Staples Sector SEC Filings — March 06, 2026

06-03-2026

PMV Pharmaceuticals reported FY2025 net loss of $77.7M, a 32% increase from $58.7M in FY2024, driven by R&D expenses rising 19% to $69.9M amid rezatapopt advancement, while G&A expenses fell 39% to $16.3M; cash and equivalents dropped to $112.9M from $183.3M, with net cash used in operations up to $73.6M from $51.3M, providing runway into Q2 2027. Clinical highlights include on-track PYNNACLE Phase 2 enrollment, FDA Orphan Drug Designation for rezatapopt in TP53 Y220C ovarian cancer, NEJM publication of Phase 1 data, and planned NDA submission in Q1 2027, supported by Phase 2 data showing 34% ORR across cohorts and up to 50% in ovarian cancer. However, cash burn acceleration highlights financial pressures despite promising trial progress.

• ·Median duration of response 7.6 months across all cohorts; 8.0 months in ovarian cancer cohort.
• ·Most frequent TRAEs (>15%): nausea, fatigue, blood creatinine increased, ALT increased (mostly Grade 1-2).
• ·FDA Orphan Drug Designation granted March 2, 2026 for rezatapopt in TP53 Y220C positive ovarian, fallopian tube, and primary peritoneal cancer.
• ·Phase 1 PYNNACLE results published in New England Journal of Medicine.
• ·Updated ovarian cancer ORR data presented at 2026 European Society of Gynecologic Oncology Congress.

06-03-2026

Covenant Logistics Group, Inc. (CVLG) filed a Form S-3 shelf registration statement on March 6, 2026, enabling potential future offerings of common stock, preferred stock, debt securities, rights, and warrants through various distribution methods, with proceeds usage to be specified in supplements. As of February 25, 2026, 20,383,043 Class A shares and 4,700,000 Class B shares were outstanding, with Class B shares (100% owned by David Parker and Jacqueline Parker) providing double voting rights and control over corporate actions. The prospectus incorporates risk factors from the 2025 10-K and warns of potential declines in securities value without highlighting any financial performance metrics.

• ·Class B common stock convertible 1:1 to Class A at any time and automatically converts upon transfer outside Parker family.
• ·No shares of preferred stock issued and outstanding as of February 25, 2026.
• ·Annual Report on Form 10-K referenced for year ended December 31, 2025.
• ·Quarterly Report on Form 10-Q filed August 7, 2025, includes Articles of Incorporation as exhibit.

06-03-2026

Monroe Capital Corporation (MRCC) filed a Rule 425 supplementing disclosures in response to shareholder lawsuits alleging misleading information in the Joint Proxy Statement for the proposed Asset Sale to Monroe Capital Income Plus Corporation (MCIP) and subsequent merger with Horizon Technology Finance Corporation (HRZN), with the HRZN Board unanimously recommending approval ahead of the March 13, 2026 special meeting. Supplemental projections show pro forma combined NII per share improving from $1.05 in 2026 to $1.24 in 2030 and NAV per share rising from $6.55 to $7.89; however, dividends remain flat at $1.00 per share across years, MRCC standalone NII dips to $0.26 in 2027 before slight recovery to $0.31, and HRZN standalone NII remains largely flat around $1.02-$1.06.

• ·Merger Agreement and Asset Purchase Agreement both dated August 7, 2025
• ·Joint Proxy Statement dated January 16, 2026; delivered January 20, 2026
• ·Putative class action complaints filed starting January 30, 2026 in Delaware Court of Chancery and New York Supreme Court
• ·HRZN Special Meeting: March 13, 2026 at 2:30 p.m. ET, 312 Farmington Avenue, Farmington, Connecticut 06032
• ·Projections prepared as of June 30, 2025 by MC Advisors and HRZN Advisor
• ·Financial advisors: Houlihan Lokey (MRCC Special Committee), Oppenheimer (HRZN Special Committee)

06-03-2026

On February 17, 2026, Addentax Group Corp. agreed to purchase 34,200,000 common shares of KEEMO Fashion Group Ltd from Guang Wen Global Limited for approximately $5.5 million, satisfied by transferring a portion of an existing $17.5M bond originally issued on August 24, 2023. The deal is set to close by May 1, 2026, positioning Addentax as the controlling shareholder with 62.18% of voting rights on a fully-diluted basis. This 8-K/A filing corrects a tagging error in the original February 19, 2026 submission under Item 8.01.

• ·Shares have par value of $0.001 per share.
• ·Bond bears 2.5% per annum interest, one-year tenor (renewable), governed by New York law.
• ·Stock Purchase Agreement dated February 17, 2026 (Exhibit 10.1); Bond Transfer Agreement dated February 18, 2026 (Exhibit 10.2).

06-03-2026

Wheeler Real Estate Investment Trust, Inc. processed redemptions of 6,502 shares of Series D Cumulative Convertible Preferred Stock on March 5, 2026, at approximately $41.72 per share (including accrued dividends), settling via issuance of 143,914 shares of common stock at a volume-weighted average price of $1.88. This triggered a further adjustment to the conversion price of its 7.00% Subordinated Convertible Notes due 2031 to approximately $1.04 per share (24.12 shares per $25 principal), a 45% discount to $1.88. Cumulatively, 1,777,083 Series D shares have been redeemed with approximately 393,000 common shares issued; as of March 6, 2026, 1,433,983 common shares and 1,640,295 Series D shares remain outstanding.

• ·Next Series D redemption deadline: March 25, 2026; next Holder Redemption Date: April 6, 2026
• ·Redemption forms and FAQs available at https://ir.whlr.us/series-d/series-d-redemption

06-03-2026

United States Antimony Corporation (UAMY) filed an 8-K on March 6, 2026, under Item 3.01 notifying of delisting or failure to satisfy a continued listing rule or standard, a material negative development for shareholders. The filing also furnishes Exhibit 99.1, a press release under Item 7.01 (Regulation FD Disclosure), which includes forward-looking statements on the company's plans and potential benefits from a joint venture. No financial metrics or period comparisons were provided.

• ·Filing items include 3.01 (Notice of Delisting/Failure to Satisfy Rule), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits).
• ·Exhibit 99.1 is a Press Release dated March 6, 2026, furnished but not deemed 'filed' under the Exchange Act.

06-03-2026

Mammoth Energy Services reported Q4 2025 revenue from continuing operations of $9.5M, down 5% YoY from $10.0M and 13% QoQ from $10.9M, with full-year revenue at $44.3M, down 3% YoY from $45.6M; net loss widened to $12.3M in Q4 (vs $9.6M YoY) but improved FY to $63.8M from $183.1M. While rental services revenue surged 175% YoY to $3.3M and infrastructure grew 200% to $1.2M, natural sand proppant declined 67% YoY to $1.7M and accommodation fell 17% FY YoY; Adjusted EBITDA remained negative at ($6.8M) Q4, though FY improved significantly to ($17.4M). Four divestitures generated over $150M in cash, bolstering liquidity to $158.3M at year-end, with $65M+ deployed into high-growth aviation rentals.

• ·SG&A expense FY 2025: $19.6M vs $114.5M in 2024 (83% decline, due to lower expected credit losses on PREPA settlement).
• ·Drilling services FY revenue flat at $3.7M vs $3.6M YoY (+3%).
• ·As of Mar 3, 2026, total liquidity $156.6M (cash $89.6M, marketable securities $28.8M).
• ·Q4 sand avg sales price $18.56/ton vs $22.54 YoY (-18%).

06-03-2026

Clover Health Investments, Corp. (CLOV) published written responses to a selection of frequently asked supplemental shareholder questions related to its fourth quarter 2025 earnings announcement on March 6, 2026. The Q&A is furnished as Exhibit 99.1 to this Form 8-K and available on the company's investor relations website. This disclosure is pursuant to Regulation FD and not deemed 'filed' for purposes of the Exchange Act.

• ·Related to fourth quarter 2025 earnings announcement.
• ·Securities registered: Class A Common Stock, par value $0.0001 per share (CLOV).
• ·Remote-first company with no physical headquarters; communications to secretary@cloverhealth.com.

06-03-2026

GXO Logistics, Inc. appointed Mark Suchinski as Chief Financial Officer effective April 1, 2026, bringing over three decades of finance, operations, and supply chain experience, particularly in aerospace and defense. CEO Patrick Kelleher stated that the leadership team is now fully in place to drive faster growth and higher margins. The company operates over 150,000 team members across more than 1,000 facilities totaling more than 200 million square feet.

• ·Mark Suchinski previously served as CFO for The GEO Group, Inc. and Spirit AeroSystems.
• ·Patrick Kelleher joined GXO in August 2025.
• ·Suchinski holds a Bachelor of Business Administration from DePaul University.

06-03-2026

ArteLo Biosciences, Inc. (ARTL) filed an 8-K on March 6, 2026, reporting material modifications to the rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). The filing falls under the subcategory of Charter/Bylaws Amendments, indicating potential changes to corporate governance structure. No financial metrics or period-over-period comparisons were disclosed in the available filing details.

• ·Filing accession number: 0001640334-26-000395
• ·Company CIK: 0001621221
• ·SIC: 2834 (Pharmaceutical Preparations)
• ·Incorporated in NV, located in CA, Fiscal Year End: December 31
• ·Former names: Knight Knox Development Corp. (through 2017-02-06), Reactive Medical Inc. (through 2017-04-17)

06-03-2026

Deric Eubanks voluntarily terminates employment with Ashford Hospitality Advisors, LLC on March 31, 2026, without Good Reason, in exchange for a release and waiver agreement. He receives a $1.8M Non-Compete Payment paid over 12 months, $200K transition payment through June 30, 2026, eligibility for a prorated 2025 Cash Incentive Bonus, and continued vesting of $3.3M in deferred cash grants and 13,490 AINC shares subject to compliance with consulting and restrictive covenants. Mutual releases, non-disparagement, and ongoing non-compete (12 months), non-solicitation (24 months) obligations are affirmed.

• ·Non-compete period: 12 months post-termination
• ·Non-solicitation and standstill periods: 24 months post-termination
• ·Payments subject to 8-day revocation period and compliance with consulting (remote, reasonable requests)
• ·Original employment agreement effective January 1, 2023

06-03-2026

Korn Ferry (NYSE: KFY) announced the election of Pete Shimer, former Chief Operating Officer of Deloitte U.S., to its Board of Directors, with appointments to the Audit Committee and Nominating and Corporate Governance Committee. Shimer brings extensive consulting, operational, financial, and strategic investment expertise from his Deloitte career, including roles as Interim CEO, CFO, and Lead Client Service Partner for Fortune 500 clients. CEO Gary D. Burnison and Non-Executive Chair Jerry Leamon highlighted his value in enhancing board capabilities.

• ·Pete Shimer earned a Bachelor of Arts in Accounting from the University of Washington.
• ·Shimer currently serves as Executive Committee Chair of the Cancer Artificial Intelligence Alliance, Board member of Alaska Air Group (Audit and Safety Committees), Synopsys (Audit Committee), Fred Hutchinson Cancer Center (Executive Committee Vice Chair), and University of Washington Foster School of Business.
• ·Filing references Korn Ferry’s Annual Report on Form 10-K for fiscal year ended April 30, 2025.

06-03-2026

Honeywell announced that Honeywell Aerospace Inc. has launched a private offering of up to $16B in senior notes and entered into $3B five-year and $1B 364-day revolving credit facilities to finance the planned spin-off of Aerospace, expected in Q3 2026. Proceeds from New Money Notes will fund a cash distribution to Honeywell and related fees, while Exchange Notes settle prior debt obligations. However, the offering size, timing, and terms are subject to market conditions, with significant risks including potential delays, failure to complete the spin-off, or lack of anticipated benefits.

• ·Notes offered only to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S
• ·Notes guaranteed by Honeywell until Spin-Off completion, after which guarantees are automatically released
• ·Closing of Notes offering not contingent on Spin-Off completion

06-03-2026

ArcelorMittal's total sales declined 1.7% YoY to $61.4B in 2025 from $62.4B in 2024, driven by drops in Brazil (-9.9%), Europe (-3.9%), and Sustainable Solutions (-2.1%), despite gains in Mining (+21.4%) and North America (+3.7%). Operating income rose 9.6% YoY to $3.6B, with strong growth in North America (+68.3%), Sustainable Solutions (+149.1%), and Europe (+35.2%), but offset by a sharp decline in Brazil (-56.5%) and flat Mining performance (+2.5%). North America saw crude steel production up 2.9% to 7.8M tonnes, though long product shipments fell 4.3%.

• ·North America flat product shipments: 8,378 thousand tonnes (+4.4% YoY)
• ·North America long product shipments: 2,378 thousand tonnes (-4.3% YoY)
• ·North America average steel selling price: $1,014/tonne (+2.9% YoY)
• ·North America total steel shipments: 10,283 thousand tonnes (+2.2% YoY)

06-03-2026

On March 5, 2026, Lakeland Financial Corporation's board of directors amended its share repurchase program, increasing the total authorization from $30M to $60M for common stock repurchases until April 30, 2027. As of that date, approximately $34M remains available under the amended program. Repurchases may occur via open market, block trades, or private negotiations, though the program does not obligate any specific purchases and can be modified or suspended at any time.

• ·Repurchases authorized in open market, block trades, or privately negotiated transactions

06-03-2026

MOBIX Labs, Inc. is seeking shareholder approval at its annual meeting for the election of three Class II directors (David Aldrich, Frederick Goerner, and Keyvan Samini), ratification of PricewaterhouseCoopers LLP as independent auditors for FY2026, and authorization for a reverse stock split (1:10 to 1:50 ratio) to address Nasdaq minimum bid price noncompliance, with a compliance extension until April 27, 2026. Auditor fees declined 19.5% YoY to $1.56M in FY2025 (ended Sep 30, 2025) from $1.93M in FY2024, while all other fees remained flat at $2,000. The board recommends voting for all proposals amid ongoing efforts to maintain Nasdaq listing.

• ·Nasdaq noncompliance notice received April 28, 2025; initial 180-day compliance period ended October 27, 2025; extension granted to April 27, 2026.
• ·PWC has audited financial statements since 2022.
• ·Board structure: three classes with staggered three-year terms; Class B holders elect three Class B Directors (one per class).

06-03-2026

Ardmore Shipping Corp's 20-F annual report highlights estimates of liquidity needs for 2026 and longer term to fund capital expenditures, acquisitions, refinancing, and general corporate activities. It discusses risks including adverse impacts from oil price declines potentially reducing growth opportunities and high debt levels limiting financing flexibility. The company emphasizes its low cost structure for operating expenses and overhead, with operations primarily under time charters, commercial pools, and spot charters where it bears vessel operating expenses.

• ·Filing date: March 06, 2026
• ·Vessel operating expenses include crewing, repairs and maintenance, insurance, stores, lube oils, communication expenses, and technical management fees

06-03-2026

Velo3D, Inc. amended its January 2025 Senior Secured Convertible Note ($5M principal, now held by Arrayed Notes Acquisition Corp., controlled by CEO Arun Jeldi) to allow optional conversion of principal and accrued interest into common stock, following prior amendments extending maturity to February 14, 2027, and reducing interest to 12% per annum. The February 2025 Senior Secured Convertible Note ($10M principal, held by Thieneman Construction, Inc., controlled by director Kenneth Thieneman) was also amended to permit conversion of accrued interest into common stock, with the same prior maturity extension and interest rate reduction. No changes to principal amounts or other core terms were reported.

• ·January 2025 Note prior conversion price: $16.38 per share
• ·February 2025 Note prior conversion price: $10.50 per share
• ·Both notes maturity date extended to February 14, 2027 (prior amendment)
• ·Amendments dated March 4, 2026; filing dated March 6, 2026

06-03-2026

Sonic Automotive, Inc. (SAH) filed Definitive Additional Proxy Materials (DEFA14A) on March 06, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing, marked as soliciting material under §240.14a-12, was submitted by the registrant with no fee required. No specific proposals, financial data, or substantive details are provided in the filing header.

06-03-2026

Modular Medical, Inc. (MODD) announced the pricing of a $12.0 million public offering of 68,098,000 shares of common stock (or pre-funded warrants) and accompanying warrants at $0.1762 per share, priced at a premium to market. The warrants are exercisable immediately at $0.1762 and expire in five years, with gross proceeds expected before fees and expenses. Closing is anticipated on or about March 4, 2026, with Maxim Group LLC as sole placement agent.

• ·Warrants exercisable immediately upon issuance and expire five years from issuance date.
• ·Offering pursuant to effective S-1 registration statement (File No. 333-293842) declared effective March 3, 2026.
• ·SEC filing date: March 06, 2026; Press release date: March 3, 2026.

06-03-2026

On March 3, 2026, Valmont Industries, Inc. dismissed Deloitte & Touche LLP as its independent registered public accounting firm and appointed KPMG LLP for the fiscal year ending December 26, 2026, following Audit Committee approval. There were no disagreements, reportable events, or prior consultations with KPMG during fiscal years ended December 27, 2025, and December 28, 2024, and Deloitte's audit reports for those years were unqualified. Deloitte provided a concurring letter as Exhibit 16.1.

• ·Appointment of KPMG subject to completion of client acceptance procedures and execution of engagement letter.
• ·Deloitte's letter dated March 5, 2026, filed as Exhibit 16.1.

06-03-2026

On March 4, 2026, Funko, Inc. and its subsidiary Funko UK, Ltd. entered into a Letter Agreement amending Andrew Oddie's Service Agreement dated May 12, 2022 (as previously modified), changing his title to Chief International Officer, eliminating his U.S. residency requirement for employment, and removing certain relocation terms while keeping his compensation otherwise unchanged. The amendment does not indicate any departure or new appointment but adjusts existing terms. Full details are in Exhibit 10.1.

• ·Original Service Agreement dated May 12, 2022, modified by letters dated May 1, 2024 and September 9, 2024.
• ·Filing signed on March 6, 2026.

06-03-2026

Nathan’s Famous, Inc. has filed a preliminary proxy statement (PREM14A) for a special virtual stockholder meeting in 2026 to approve the Merger Proposal, a non-binding Compensation Advisory Proposal, and an Adjournment Proposal, with the Board unanimously recommending votes 'FOR' all items and directors/executives subject to a Voting Agreement supporting the merger. The merger, if approved, is expected to close in the first half of 2026, with appraisal rights available under DGCL Section 262 for dissenting stockholders. As of December 28, 2025, the company operated 225 restaurant locations, including 113 franchised.

• ·Special Meeting to be held virtually via audio webcast; record date [•], 2026.
• ·Merger requires majority of outstanding shares; abstentions/broker non-votes count as 'AGAINST'.
• ·Proxy solicitation expenses borne by company; no additional compensation to directors/officers/employees.

06-03-2026

Kratos Defense & Security Solutions, Inc. completed its acquisition of Orbit Technologies Ltd. on March 2, 2026, via a merger, acquiring 100% of Orbit's ordinary shares for approximately $352.7 million in cash funded from its balance sheet, at $13.725 per share. Orbit, previously publicly traded on the Tel Aviv Stock Exchange, is now an indirect wholly owned subsidiary of Kratos. No financial impacts or performance metrics were disclosed in this filing.

• ·Merger Agreement dated November 4, 2025, previously disclosed in 8-K filed November 7, 2025
• ·Orbit ordinary shares delisted from Tel Aviv Stock Exchange post-merger
• ·All outstanding Orbit options fully vested and canceled for cash payment based on Merger Consideration

06-03-2026

O’Reilly Automotive, Inc. entered into an Underwriting Agreement on March 5, 2026, with BofA Securities, Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities, LLC as representatives of the underwriters for the issuance and sale of $850M aggregate principal amount of 5.100% Senior Notes due 2036. Estimated net proceeds of approximately $841M will be used to repay outstanding 3.550% senior notes due 2026 at maturity, repay a portion of commercial paper borrowings, and for general corporate purposes including working capital, share repurchases, acquisitions, and related fees.

• ·Underwriting Agreement includes customary representations, warranties, covenants, and indemnification of underwriters against certain liabilities.
• ·Common stock ($0.01 par value) trades on NASDAQ Global Select Market under symbol ORLY.

06-03-2026

Krispy Kreme reported FY2025 net revenues of $1.52B, down 8.6% YoY from $1.67B, driven by U.S. declines of 13.8% and impacts from Insomnia Cookies divestiture, though International revenues grew 3.1% YoY to $535M. The company posted a significant net loss of $524M versus $4M profit in FY2024, primarily due to $356M goodwill impairment and $56M shop closure expenses, with Adjusted EBITDA falling 27.5% to $140M. Organic revenue declined 1.3% overall, with U.S. organic down 3.5% while International organic rose 3.3%.

• ·U.S. sales per Hub declined to $4.7M from $4.9M YoY.
• ·International sales per Hub declined to $9.7M from $9.9M YoY.
• ·Market Development revenues declined 14.9% YoY to $74M.
• ·Corporate expenses within Adjusted EBIT increased 9.3% to $76M.

06-03-2026

At the 2026 Annual Meeting of Stockholders on March 4, 2026, Helmerich & Payne, Inc. stockholders elected 10 directors, including Raymond John Adams III (80.4M for, 0.9M against), Randy A. Foutch (70.9M for, 10.4M against), and John D. Zeglis (75.0M for, 6.3M against), while most received over 79M for votes. Stockholders also ratified Ernst & Young LLP as auditors for fiscal year ending September 30, 2026 (89.1M for, 3.2M against), approved executive compensation advisory vote (79.2M for, 1.9M against), and approved the Amended & Restated 2024 Omnibus Incentive Plan (76.3M for, 4.9M against), with consistent broker non-votes of 11.0M across proposals.

• ·Proxy Statement filed with SEC on January 22, 2026, includes full text of A&R 2024 Plan as Appendix A
• ·Fiscal year ends September 30, 2026

06-03-2026

International Money Express, Inc. (IMXI) reported total revenues of $608M for FY 2025, down 8% YoY from $659M in 2024, primarily due to a 9% decline in wire transfer and money order fees to $502M, while foreign exchange gains were flat at $87M and other income grew 24% to $18M. Net income dropped sharply 44% to $33M from $59M, with operating income falling 41% to $56M amid elevated transaction costs ($10M), goodwill impairment ($1M), and higher SG&A expenses. Adjusted EBITDA declined 20% to $97M from $121M, though restructuring costs decreased significantly to $1M.

• ·Total operating expenses $552M (91% of revenues) in FY2025 vs $564M (86% of revenues) in FY2024.
• ·Transaction costs rose to $10M in FY2025 from $2M in FY2024.
• ·GAAP diluted EPS $1.08 in FY2025 vs $1.79 in FY2024; Adjusted diluted EPS $1.66 vs $2.14.
• ·Net cash used in investing activities $22M in FY2025 vs $44M in FY2024.
• ·Cash and cash equivalents increased to $169M at end of FY2025 from $131M.

06-03-2026

On February 25, 2026, American Rebel Holdings, Inc. received a $250,000 release from a deposit account control agreement tied to a prior $5.47M secured promissory note with Streeterville Capital, LLC. Simultaneously, the company exchanged 490 shares of Series E Preferred Stock for 2,450,000 shares of common stock via five Exchange Agreements, resulting in significant equity dilution for existing shareholders. These transactions were exempt from registration under Section 4(a)(2) and Regulation D.

• ·Original note purchase agreement dated June 26, 2025.
• ·Series E Preferred Stock originally issued pursuant to August 22, 2025 Note Purchase Agreement.
• ·Five identical Exchange Agreements executed, varying only in conversion amounts and shares.

06-03-2026

IPG Photonics Corporation filed Amendment No. 1 to its Form 10-K for the fiscal year ended December 31, 2025, solely to correct the cover page disclosure regarding incorporation by reference to its proxy statement for the 2026 Annual Meeting; no changes were made to financial statements or other disclosures from the original filing on February 23, 2026. The amendment includes new Section 302 certifications but omits others as no financials are revised. Aggregate market value of non-affiliate common stock was approximately $1.8B as of June 30, 2025, with 42,191,353 shares outstanding as of February 20, 2026.

• ·Registrant is a large accelerated filer.
• ·Proxy statement for 2026 Annual Meeting to be filed within 120 days of December 31, 2025.

06-03-2026

HF Sinclair Corporation (DINO) appointed Vivek Garg, age 52, as Acting Chief Financial Officer effective February 24, 2026, while he continues in his roles as Vice President, Chief Accounting Officer, and Controller. As additional compensation, Garg will receive a $25,000 monthly cash stipend commencing March 1, 2026, and a one-time $375,000 restricted stock unit grant vesting 50% on December 1, 2026, and 50% on December 1, 2027. The appointment involves no arrangements with other persons, family relationships, or disclosable transactions under Item 404(a).

• ·Appointment previously announced in Form 10-K filed February 27, 2026
• ·Stipend prorated for partial months of service
• ·RSU governed by HF Sinclair Corporation Amended and Restated 2020 Long Term Incentive Plan
• ·Garg eligible for ongoing annual bonus, health/welfare plans, and existing Change in Control and Indemnification Agreements

06-03-2026

Global Mofy AI Ltd filed an F-3 shelf registration statement on March 6, 2026, enabling potential future offerings of securities without specific amounts or uses detailed at this time. The company reports authorized share capital of $1.02M, divided into 30B Class A ordinary shares and 4B Class B ordinary shares, each with a par value of $0.00003. As of the prospectus date, 45.8M Class A shares and 5.7M Class B shares are outstanding, with Class B shares carrying 20 votes per share compared to 1 vote for Class A.

• ·Incorporated as a Cayman Islands exempted company on September 29, 2021.
• ·Former name: Global Mofy Metaverse Ltd (changed February 25, 2022).
• ·Class A Ordinary Shares: 1 vote per share; Class B Ordinary Shares: 20 votes per share.
• ·SEC file number: 333-294113.

06-03-2026

Perfect Moment Ltd. entered into a Further Amended and Restated Promissory Note with Chairman Max Gottschalk on March 6, 2026, extending the maturity date of a $3.39M unsecured loan (originally Note #1, part of $5.09M total loans provided in August 2025) from March 9, 2026, to March 23, 2026, at 12% interest. This follows prior amendments, including one on October 30, 2025. The second $1.7M note remains due August 18, 2030.

• ·Loans are unsecured with monthly interest payments.
• ·Note #1 originally due November 8, 2025; first amended October 30, 2025 to March 9, 2026.
• ·Note #2 due August 18, 2030.

06-03-2026

iQSTEL Inc. filed an 8-K on March 6, 2026, furnishing a Corporate Presentation under Item 7.01 Regulation FD Disclosure for use in investor meetings. The presentation provides updates on current operations, major projects, strategic plans, growth initiatives, outlook, and forecasts for future performance and industry development. No specific financial metrics or period-over-period comparisons are disclosed in the filing.

06-03-2026

Arcellx, Inc. filed an SC 14D9 tender offer response statement disclosing Centerview Partners LLC's fairness opinion dated February 23, 2026, confirming that the merger consideration is fair, from a financial point of view, to holders of common shares (excluding certain excluded shares). The filing summarizes financial projections for the fiscal year ended December 31, 2025, and beyond, prepared on a standalone basis without reflecting the proposed merger or tender offer effects, with extensive disclaimers on their speculative nature and lack of updates. Centerview's analysis reviewed historical 10-Ks (2022-2024), interim reports, internal forecasts, and comparables, but no specific deal value or performance metrics were quantified.

• ·Fairness opinion initially rendered orally on February 22, 2026
• ·Projections cover fiscal year ended December 31, 2025 and subsequent periods
• ·Centerview reviewed 10-Ks for years ended December 31, 2022, 2023, and 2024